MED-EL press releaseMED-EL, September 29, 2026
MED-EL's launch announcement, CE mark, not FDA-approved.
MED-EL TICI UNICO product pageMED-EL
Battery, charging, water, MRI conditions and processor mode, as company data.
MED-EL blog: TICI questions answeredMED-EL, November 9, 2026
First commercial surgeries in Austria and Germany; no age requirements, as MED-EL states it.
British Cochlear Implant Group leafletBritish Cochlear Implant Group, October 3, 2026
UK and NHS position, candidacy, children, waiting and switching, open questions.
HearingTrackerHearingTracker
Launch markets, number implanted, price and reimbursement, unpublished trial results.
IEEE SpectrumIEEE Spectrum (press report), September 30, 2026
Four commercial surgeries took place on the morning of MED-EL's announcement.
Cochlear Ltd media releaseCochlear Ltd, September 28, 2026
Cochlear’s research program and pivotal trial recruitment.
Cochlear Ltd AGM addresses (ASX)Cochlear Ltd, October 26, 2026
Cochlear calls its system TICI, in its third generation, and gives no timeline.
ClinicalTrials.gov NCT07139327 (ENTERPRISE)ClinicalTrials.gov
ENTERPRISE sites, recruitment and estimated completion.
ClinicalTrials.gov NCT07287124 (ELEVATE)ClinicalTrials.gov
ELEVATE sites, recruitment and estimated completion.
ClinicalTrials.gov NCT06642935ClinicalTrials.gov
Cochlear’s smaller study in Melbourne.
Envoy Medical third-quarter results releaseEnvoy Medical, November 5, 2026
Acclaim trial and FDA application progress; gives no FDA decision date.
Envoy Medical news releaseEnvoy Medical, October 20, 2026
Acclaim trial progress and FDA timing, as a company forecast.
ClinicalTrials.gov NCT06699797 (Acclaim)ClinicalTrials.gov
Acclaim pivotal trial sites and size.
Lefebvre et al., Communications Medicine (2025)Peer-reviewed
MED-EL feasibility study results in 6 adults.
Briggs et al., Ear and HearingPeer-reviewed
Cochlear’s earlier-generation study results in 10 adults.
Dornhoffer et al., J Clin Med (2023)Peer-reviewed
How the Acclaim system picks up sound, and who it suits.
BfArM procedure-code proposal (German)BfArM, Germany
German cost note.
Poland InsightPoland Insight, October 20, 2026
Poland timing and price not announced.
Health Canada Medical Devices Active Licence ListingHealth Canada
Canada: no licence found.
European Commission, CE markingEuropean Commission
What a CE mark means, and that it is not the EU approving a product as safe.
EU Medical Device Regulation 2017/745European Union
Cochlear implants are class III: a notified body assesses them, and studies in people are required (Articles 52 and 61, Annex VIII).
FDA, premarket approval (PMA)US Food and Drug Administration
How the FDA reviews class III medical devices before they can be sold in the US.